Follow
Kathryn Gold
Kathryn Gold
Verified email at ucsd.edu
Title
Cited by
Cited by
Year
Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing
J Zhang, J Fujimoto, J Zhang, DC Wedge, X Song, J Zhang, S Seth, ...
Science 346 (6206), 256-259, 2014
10062014
Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trial
AT Shaw, L Gandhi, S Gadgeel, GJ Riely, J Cetnar, H West, DR Camidge, ...
The lancet oncology 17 (2), 234-242, 2016
6982016
Osimertinib in pretreated T790M-positive advanced non-small-cell lung cancer: AURA study phase II extension component.
JC Yang, MJ Ahn, DW Kim, SS Ramalingam, LV Sequist, S Wc, SW Kim, ...
Journal of Clinical Oncology, 1288-1296, 2017
5762017
Phase III randomized trial of ipilimumab plus etoposide and platinum versus placebo plus etoposide and platinum in extensive-stage small-cell lung cancer
M Reck, A Luft, A Szczesna, L Havel, SW Kim, W Akerley, MC Pietanza, ...
Journal of Clinical Oncology 34 (31), 3740-3748, 2016
5102016
Activity and safety of brigatinib in ALK-rearranged non-small-cell lung cancer and other malignancies: a single-arm, open-label, phase 1/2 trial
SN Gettinger, LA Bazhenova, CJ Langer, R Salgia, KA Gold, R Rosell, ...
The Lancet Oncology 17 (12), 1683-1696, 2016
3582016
Eat and exercise during radiotherapy or chemoradiotherapy for pharyngeal cancers: use it or lose it
KA Hutcheson, MK Bhayani, BM Beadle, KA Gold, EH Shinn, SY Lai, ...
JAMA otolaryngology–head & neck surgery 139 (11), 1127-1134, 2013
2342013
Small cell lung cancer, version 2.2022, NCCN clinical practice guidelines in oncology
AKP Ganti, BW Loo, M Bassetti, C Blakely, A Chiang, TA D'Amico, ...
Journal of the National Comprehensive Cancer Network 19 (12), 1441-1464, 2021
1712021
Targeted therapies in squamous cell carcinoma of the head and neck
KA Gold, HY Lee, ES Kim
Cancer: Interdisciplinary International Journal of the American Cancer …, 2009
1632009
Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor–Resistant, EGFR-Mutated Non–Small Cell Lung Cancer
PA Jänne, C Baik, WC Su, ML Johnson, H Hayashi, M Nishio, DW Kim, ...
Cancer discovery 12 (1), 74-89, 2022
1572022
Relationship between tumor size and survival in non–small-cell lung cancer (NSCLC): an analysis of the surveillance, epidemiology, and end results (SEER) registry
J Zhang, KA Gold, HY Lin, SG Swisher, Y Xing, JJ Lee, ES Kim, ...
Journal of Thoracic Oncology 10 (4), 682-690, 2015
1542015
Exploratory analysis of brigatinib activity in patients with anaplastic lymphoma kinase-positive non–small-cell lung cancer and brain metastases in two clinical trials
DR Camidge, DW Kim, M Tiseo, CJ Langer, MJ Ahn, AT Shaw, RM Huber, ...
Journal of Clinical Oncology 36 (26), 2693-2701, 2018
1432018
Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial
AG Sacco, R Chen, FP Worden, DJL Wong, D Adkins, P Swiecicki, ...
The Lancet Oncology 22 (6), 883-892, 2021
1392021
Computed tomography RECIST assessment of histopathologic response and prediction of survival in patients with resectable non–small-cell lung cancer after neoadjuvant chemotherapy
WN William Jr, A Pataer, N Kalhor, AM Correa, DC Rice, II Wistuba, ...
Journal of Thoracic Oncology 8 (2), 222-228, 2013
1222013
Selective antitumor activity of ibrutinib in EGFR-mutant non–small cell lung cancer cells
W Gao, M Wang, L Wang, H Lu, S Wu, B Dai, Z Ou, L Zhang, JV Heymach, ...
Journal of the National Cancer Institute 106 (9), dju204, 2014
1112014
Immune modulation of head and neck squamous cell carcinoma and the tumor microenvironment by conventional therapeutics
S Miyauchi, SS Kim, J Pang, KA Gold, JS Gutkind, JA Califano, LK Mell, ...
Clinical Cancer Research 25 (14), 4211-4223, 2019
1072019
Erlotinib in the treatment of recurrent or metastatic cutaneous squamous cell carcinoma: a single‐arm phase 2 clinical trial
KA Gold, MS Kies, WN William Jr, FM Johnson, JJ Lee, BS Glisson
Cancer 124 (10), 2169-2173, 2018
1022018
Probing the building blocks of eumelanins using scanning electron microscopy
JB Nofsinger, SE Forest, LM Eibest, KA Gold, JD Simon
Pigment Cell Research 13 (3), 179-184, 2000
982000
Safety and efficacy of pembrolizumab with chemoradiotherapy in locally advanced head and neck squamous cell carcinoma: a phase IB study
SF Powell, KA Gold, MM Gitau, CJ Sumey, MM Lohr, SC McGraw, ...
Journal of Clinical Oncology 38 (21), 2427, 2020
952020
Relation between the level of lymph node metastasis and survival in locally advanced head and neck squamous cell carcinoma
Y Xing, J Zhang, H Lin, KA Gold, EM Sturgis, AS Garden, JJ Lee, ...
Cancer 122 (4), 534-545, 2016
952016
Safety and efficacy of brigatinib (AP26113) in advanced malignancies, including ALK+ non–small cell lung cancer (NSCLC).
DR Camidge, L Bazhenova, R Salgia, CJ Langer, KA Gold, R Rosell, ...
Journal of Clinical Oncology 33 (15_suppl), 8062-8062, 2015
802015
The system can't perform the operation now. Try again later.
Articles 1–20